Company Profile: Stemcell United Ltd (ASX: SCU) is a small-cap biotechnology company that works on growth and extraction of stem cells for diverse applications including medicinal, health and beauty applications. The group is a holder of Dendrobium stem-cell patents and its products are based on Dendrobium Officinale and Daemonorops Draco Blume, plant extracts with high demand and use in a wide range of products. The group is well positioned to commercialise the use of their proprietary technology for cannabis stem cell extraction in cooperation with Yunnan Hua Fang Industrial Hemp Co Ltd.
Start discussion with value Investors for ASX Stock Market Investment and Opinion.
Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s
Those phrases have become increasingly common as marijuana legalization spreads.
Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500. Click here for your FREE Report